Hot Features
Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with... Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.35 | -5.69105691057 | 6.15 | 6.15 | 5.75 | 1414142 | 5.84697986 | DE |
| 4 | -1 | -14.7058823529 | 6.8 | 7.06 | 5.75 | 1966066 | 6.3211984 | DE |
| 12 | -2.5 | -30.1204819277 | 8.3 | 9.55 | 5.75 | 2468029 | 7.60775795 | DE |
| 26 | -5.4 | -48.2142857143 | 11.2 | 12.25 | 5.75 | 2207062 | 8.92555182 | DE |
| 52 | 3.225 | 125.242718447 | 2.575 | 12.45 | 2.4 | 2823620 | 7.86996841 | DE |
| 156 | -0.95 | -14.0740740741 | 6.75 | 12.75 | 1.075 | 3136354 | 5.19291708 | DE |
| 260 | -52.2 | -90 | 58 | 60 | 1.075 | 2371191 | 7.09016082 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.